Orchid Chemicals Pharma

Rediff.com » News » Orchid Chemicals Pharma

News for Orchid Chemicals Pharma

Business

Should you buy mid-cap and small-cap stocks?

One needs to be cautious despite the uptick seen on Monday, as the real test of the rally in this segment will be the upcoming result season, analysts say Stocks from the mid-cap and small-cap......

'I doubt if Sahara is serious about selling properties'

Owners of Pune-based Serum Institute of India, the Poonawalla’s have thrown the hat to acquire the iconic Grosvenor Hotel in UK from Sahara Group. Adar Poonawalla (bottom Left), CEO of Serum......

Markets extend losses for third straight day

Benchmark share indices ended lower for the third straight session as investors turned cautious amid tensions in Iraq even as consumer durables shares stole the limelight tracking rally in gold......

Markets end flat on profit taking

Benchmark share indices came off their day's highs to end marginally higher as investors booked profits after they touched fresh all-time highs in intra-day trades today. The 30-share Sensex ended......

Pharma R&D: Basic drug research only a part

A review of the expenditure on research and development in the books of several top domestic and multinational drug makers shows this includes cost incurred on generic development, regulatory......

Rediff News

Orchid Chemicals Pharma

News for Orchid Chemicals Pharma

Should you buy mid-cap and small-cap stocks?

'I doubt if Sahara is serious about selling properties'

Markets extend losses for third straight day

Markets end flat on profit taking

Pharma R&D: Basic drug research only a part

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS